Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.

Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q36293637
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinomaA targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva.Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targetsGenome-wide gene expression profiling of tongue squamous cell carcinoma by RNA-seq.Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - A singe institute's experience in Taiwan.Proteomic profiling of the cancer cell secretome: informing clinical research.Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes.Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis.Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.XIAP 3'-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma.Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.Let-7c inhibits migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2.Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
P2860

Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q36293637
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@ast
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@en
type
label
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@ast
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@en
prefLabel
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@ast
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Low-molecular-mass secretome p ...... avity squamous cell carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P698
P921
P932